SpringWorks closes common stock offering
SpringWorks Therapeutics reports the closing of its underwritten public offering of 5,637,254 shares of its common stock at a public offering price of $51.00 per share....
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
SpringWorks Therapeutics reports the closing of its underwritten public offering of 5,637,254 shares of its common stock at a public offering price of $51.00 per share....
Pangolin Therapeutics is a chemistry-driven platform company using Yale Professor and Co-founder Andrew Miranker’s PangomerTM technology to design novel small molecule therapeutics targeting mis-assembly of...
Yale scientists will build the next-generation human brain PET scanner, the NeuroeXplorer (NX), to be installed at the Yale Positron Emission Tomography (PET) Center in...
Canaan Partners raised $800 million in its 12th fund to back early-stage healthcare and technology companies, equaling the sum it picked up in its 11th...
The longtime chief operating officer of one of the state’s four licensed medical marijuana growers is now also its president. Connecticut Pharmaceutical Solutions, which has...
The National Institutes of Health has provided research support to two members of the Yale School of Medicine faculty through its Rapid Acceleration of Diagnostics...
UConn recently funded five COVID-19 research projects and has announced plans for additional funding … more Separately, the longtime leader of UConn School of Medicine’s...
Connecticut Innovations has reported final investment figures from its recently completed fiscal year. Between July 1, 2019, and June 30, 2020, CI invested $43.2 million...
A study of 50 critically ill patients at Yale New Haven Hospital found a Guilford company’s portable MRI could successfully detect brain abnormalities at their...
A study of 50 critically ill patients at Yale New Haven Hospital found a Guilford company’s portable MRI could successfully detect brain abnormalities at their...